Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants.

Markert ML, Devlin BH, Alexieff MJ, Li J, McCarthy EA, Gupton SE, Chinn IK, Hale LP, Kepler TB, He M, Sarzotti M, Skinner MA, Rice HE, Hoehner JC.

Blood. 2007 May 15;109(10):4539-47. Epub 2007 Feb 6.

2.

T-B+NK+ severe combined immunodeficiency caused by complete deficiency of the CD3zeta subunit of the T-cell antigen receptor complex.

Roberts JL, Lauritsen JP, Cooney M, Parrott RE, Sajaroff EO, Win CM, Keller MD, Carpenter JH, Carabana J, Krangel MS, Sarzotti M, Zhong XP, Wiest DL, Buckley RH.

Blood. 2007 Apr 15;109(8):3198-206. Epub 2006 Dec 14.

3.

Neonate-primed CD8+ memory cells rival adult-primed memory cells in antigen-driven expansion and anti-viral protection.

Fadel SA, Cowell LG, Cao S, Ozaki DA, Kepler TB, Steeber DA, Sarzotti M.

Int Immunol. 2006 Feb;18(2):249-57. Epub 2006 Jan 17.

PMID:
16418189
4.

Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines.

Mascola JR, D'Souza P, Gilbert P, Hahn BH, Haigwood NL, Morris L, Petropoulos CJ, Polonis VR, Sarzotti M, Montefiori DC.

J Virol. 2005 Aug;79(16):10103-7. No abstract available.

5.

SpA: web-accessible spectratype analysis: data management, statistical analysis and visualization.

He M, Tomfohr JK, Devlin BH, Sarzotti M, Markert ML, Kepler TB.

Bioinformatics. 2005 Sep 15;21(18):3697-9. Epub 2005 Jul 28.

PMID:
16051675
6.

Statistical analysis of antigen receptor spectratype data.

Kepler TB, He M, Tomfohr JK, Devlin BH, Sarzotti M, Markert ML.

Bioinformatics. 2005 Aug 15;21(16):3394-400. Epub 2005 Jun 14.

PMID:
15955781
7.

Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases.

Markert ML, Alexieff MJ, Li J, Sarzotti M, Ozaki DA, Devlin BH, Sempowski GD, Rhein ME, Szabolcs P, Hale LP, Buckley RH, Coyne KE, Rice HE, Mahaffey SM, Skinner MA.

J Allergy Clin Immunol. 2004 Apr;113(4):734-41.

PMID:
15100681
8.

Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome.

Markert ML, Alexieff MJ, Li J, Sarzotti M, Ozaki DA, Devlin BH, Sedlak DA, Sempowski GD, Hale LP, Rice HE, Mahaffey SM, Skinner MA.

Blood. 2004 Oct 15;104(8):2574-81. Epub 2004 Apr 20.

9.
10.

Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients.

Markert ML, Sarzotti M, Ozaki DA, Sempowski GD, Rhein ME, Hale LP, Le Deist F, Alexieff MJ, Li J, Hauser ER, Haynes BF, Rice HE, Skinner MA, Mahaffey SM, Jaggers J, Stein LD, Mill MR.

Blood. 2003 Aug 1;102(3):1121-30. Epub 2003 Apr 17.

11.

T cell repertoire development in humans with SCID after nonablative allogeneic marrow transplantation.

Sarzotti M, Patel DD, Li X, Ozaki DA, Cao S, Langdon S, Parrott RE, Coyne K, Buckley RH.

J Immunol. 2003 Mar 1;170(5):2711-8.

12.

GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression.

Baker-LePain JC, Sarzotti M, Fields TA, Li CY, Nicchitta CV.

J Exp Med. 2002 Dec 2;196(11):1447-59.

13.

Enhanced type 1 immunity after secondary viral challenge in mice primed as neonates.

Fadel SA, Ozaki DA, Sarzotti M.

J Immunol. 2002 Sep 15;169(6):3293-300.

14.

T cell immunity in neonates.

Garcia AM, Fadel SA, Cao S, Sarzotti M.

Immunol Res. 2000;22(2-3):177-90. Review.

PMID:
11339354
15.

CD4+Thy1- thymocytes with a Th-type 2 cytokine response.

Cerasoli DM, Kelsoe G, Sarzotti M.

Int Immunol. 2001 Jan;13(1):75-83.

PMID:
11133836
16.

Cellular immune responses in neonates.

Fadel S, Sarzotti M.

Int Rev Immunol. 2000;19(2-3):173-93. Review.

PMID:
10763708
17.

gammadelta T cells are a component of early immunity against preerythrocytic malaria parasites.

McKenna KC, Tsuji M, Sarzotti M, Sacci JB Jr, Witney AA, Azad AF.

Infect Immun. 2000 Apr;68(4):2224-30.

18.

DNA immunization of infants: potential and limitations.

Butts C, Zubkoff I, Robbins DS, Cao S, Sarzotti M.

Vaccine. 1998 Aug-Sep;16(14-15):1444-9. Review.

PMID:
9711786
19.

Induction of cytotoxic T cell responses in newborn mice by DNA immunization.

Sarzotti M, Dean TA, Remington MP, Ly CD, Furth PA, Robbins DS.

Vaccine. 1997 Jun;15(8):795-7.

PMID:
9234516
20.

Immunologic tolerance.

Sarzotti M.

Curr Opin Hematol. 1997 Jan;4(1):48-52. Review.

PMID:
9050379
21.

Response: immunological tolerance.

Sarzotti M.

Science. 1996 Jun 7;272(5267):1408a. No abstract available.

PMID:
17770867
22.

Induction of protective CTL responses in newborn mice by a murine retrovirus.

Sarzotti M, Robbins DS, Hoffman PM.

Science. 1996 Mar 22;271(5256):1726-8.

PMID:
8596933
23.

Retrovirus-elicited interleukin-12 and tumour necrosis factor-alpha as inducers of interferon-gamma-mediated pathology in mouse AIDS.

Giese NA, Gazzinelli RT, Actor JK, Morawetz RA, Sarzotti M, Morse HC 3rd.

Immunology. 1996 Mar;87(3):467-74.

24.

Immunogenic determinants of a neuropathogenic murine leukemia virus.

Robbins DS, Remington MP, Sarzotti M, St Louis D, Hoffman PM.

J Virol. 1995 Nov;69(11):6847-51.

25.

Treatment of intracranial alphavirus infections in mice by a combination of specific antibodies and an interferon inducer.

Coppenhaver DH, Singh IP, Sarzotti M, Levy HB, Baron S.

Am J Trop Med Hyg. 1995 Jan;52(1):34-40.

PMID:
7531956
26.

Ultraviolet-light-inactivated Cas-Br-M murine leukemia virus induces a protective CD8+ cytotoxic T lymphocyte response in newborn mice.

Sarzotti M, Dean TA, Remington M, Hoffman PM.

AIDS Res Hum Retroviruses. 1994 Dec;10(12):1695-702.

PMID:
7888229
27.

IFN-gamma production in response to neuropathogenic Cas-Br-M murine leukemia virus infection.

Sarzotti M, Gomes Mda P, Hoffman PM.

Viral Immunol. 1993 Fall;6(3):207-17.

PMID:
8292227
28.
29.

Postinfection therapy of arbovirus infections in mice.

Singh IP, Coppenhaver DH, Sarzotti M, Sriyuktasuth P, Poast J, Levy HB, Baron S.

Antimicrob Agents Chemother. 1989 Dec;33(12):2126-31.

30.

The in vivo antiviral effect of CL246,738 is mediated by the independent induction of interferon-alpha and interferon-beta.

Sarzotti M, Coppenhaver DH, Singh IP, Poast J, Baron S.

J Interferon Res. 1989 Jun;9(3):265-74.

PMID:
2545791
31.

Protection of mice from Semliki Forest virus infection by lymphocytes treated with low levels of interferon.

Stanton GJ, Lloyd RE, Sarzotti M, Blalock JE.

Mol Biother. 1989;1(6):305-10.

PMID:
2558683
32.
33.

EL-4 metastases in spleen and bone marrow suppress the NK activity generated in these organs.

Sarzotti M, Baron S, Klimpel GR.

Int J Cancer. 1987 Jan 15;39(1):118-25.

PMID:
2947865
34.

Interferon-mediated protection of B16 melanoma cells from cytotoxicity by activated macrophages.

Sarzotti M, Baron S, Tyring SK, Klimpel GR.

Cell Immunol. 1986 Jun;100(1):280-7.

PMID:
2427205
35.

Characterization of cytotoxic cells generated from in vitro cultures of murine bone marrow cells.

Klimpel GR, Sarzotti M, Reyes VE, Klimpel KD.

Cell Immunol. 1985 Apr 15;92(1):1-13.

PMID:
2416478
37.
38.

Some characteristics of mouse immune (y) interferon produced by a T-lymphoma cell line.

Landolfo S, Balzi E, Sarzotti M, Negro-Ponzi A, Arnold B.

Microbiologica. 1983 Apr;6(2):101-6.

PMID:
6408352
39.

Interferon production in mixed cultures of murine leukocytes and syngeneic L1210 leukemia cells.

Sarzotti M, Giovarelli M, Forni G.

Boll Ist Sieroter Milan. 1982;61(3):218-24.

PMID:
6085676
40.

[Characteristics of cells producing immune interferon].

Sarzotti M, Landolfo S.

G Batteriol Virol Immunol. 1981 Jul-Dec;74(7-12):224-8. Italian. No abstract available.

PMID:
6813175

Supplemental Content

Loading ...
Support Center